| 000 | 00700nam a22001937a 4500 | ||
|---|---|---|---|
| 001 | D0001C000148 | ||
| 003 | DOH | ||
| 005 | 20210204144839.0 | ||
| 008 | 210204b ||||| |||| 00| 0 eng d | ||
| 245 | 0 | 0 |
_aSARS-CoV-2 testing for public health use : _bcore principles and considerations for defined use settings / _cCatharina Boehme [and two others] |
| 580 | _aIn: Lancet Glob Health 2021 DOI:https://doi.org/10.1016/S2214-109X(21)00006-1 | ||
| 650 | 2 | _aCOVID-19 Testing | |
| 650 | 2 | _aPublic Health | |
| 700 | 1 | _aBoehme, Catharina | |
| 700 | 1 | _aHannay, Emma | |
| 700 | 1 | _aSampath, Rangarajan | |
| 856 | _uhttps://www.thelancet.com/action/showPdf?pii=S2214-109X%2821%2900006-1 | ||
| 942 | _cCV | ||
| 999 |
_c2675 _d2675 |
||